Biotechnology extensive list

Biotechnology extensive list
  • Pininvest Analysis

The Biotechnology theme offers an extensive selection of biotech firms listed on the NASDAQ stock exchange

For comparison purposes, the iShares Nasdaq Biotechnology ETF IBB seeks to track the investment results of an index composed of biotechnology and pharmaceutical equities listed on the NASDAQ

The iShares fund offers a well-regarded sector view on U.S. biotechnology and pharmaceutical companies

 

The biotech selection of the theme is not weighted; performance and volatility are calculated for informative purpose only - assuming one share of each component had been invested at the beginning of the selected period

Actual performance of IBB, the tracker fund, which maybe higher or lower, depending on the weighting and  selection decided by the provider, please check the information available on the iShares Nasdaq Biotechnology  ETF site or contact your advisor

Biotechnology extensive list • Updated:

Name Ticker Exchange Sector Industry Currency Cur.Price Mkt.Cap Perf. Momentum Vol. Risk Contrib. MDD
 
AC Immune ACIU NASDAQ Health Care Drug Manufacturers -Specialty Pharma USD 7.06 507 M -7.6% Weak Down 89%   0% -51%
ACADIA Pharmaceuticals Inc ACAD NASDAQ Health Care Drug Manufacturers - Diversified USD 21.20 3.4 B -54.5% Sharp Down 79%   0% -64%
Acceleron Pharma XLRN NASDAQ Health Care Biopharmaceuticals USD 124.03 7.5 B 30.7% Neutral 43%   0% -15%
AcelRx Pharmaceuticals ACRX NASDAQ Health Care Drug Manufacturers - Diversified USD 1.28 116 M 0.0% Sharp Down 106%   1% -54%
Aclaris Therapeutics ACRS NASDAQ Health Care Biopharmaceuticals USD 27.03 1.2 B 2,115.6% Weak Up 143%   0% -19%
Acorda Therapeutics Inc ACOR NASDAQ Health Care Biopharmaceuticals USD 3.93 31 M -38.2% Sharp Down 107%   0% -63%
Adamas Pharmaceuticals Inc ADMS NASDAQ Health Care Drug Manufacturers -Specialty Pharma USD 5.10 144 M 69.4% Weak Down 85%   0% -44%
Adaptimmune Therapeutics ADAP NASDAQ Health Care Biopharmaceuticals USD 5.04 782 M 46.9% Neutral 118%   1% -67%
Adverum Biotechnologies ADVM NASDAQ Health Care Biopharmaceuticals USD 9.40 916 M -19.1% Sharp Down 84%   1% -65%
Aeglea BioTherapeutics AGLE NASDAQ Health Care Clinical trial work USD 7.95 381 M 48.3% Neutral 71%   0% -41%
Aerie Pharmaceuticals AERI NASDAQ Health Care Drug Manufacturers -Specialty Pharma USD 17.92 839 M 21.7% Neutral 58%   0% -43%
Agios Pharmaceuticals AGIO NASDAQ Health Care Drug Manufacturers -Specialty Pharma USD 55.04 3.8 B 27.4% Neutral 58%   0% -41%
Akebia Therapeutics AKBA NASDAQ Health Care Clinical trial work USD 3.06 442 M -56.6% Sharp Down 155%   1% -84%
Alexion Pharmaceuticals ALXN NASDAQ Health Care Biopharmaceuticals USD 157.54 34 B 59.8% Neutral 40%   0% -16%
Alkermes Inc. ALKS NASDAQ Health Care Biopharmaceuticals USD 19.77 3.1 B 27.1% Neutral 43%   0% -26%
Allakos ALLK NASDAQ Health Care Clinical trial work USD 108.14 5.7 B 77.4% Sharp Down 62%   0% -32%
AlloVir ALVR NASDAQ Health Care Immunotherapy USD 22.60 1.5 B -11.0% Sharp Down 88%   0% -56%
Alnylam Pharmaceuticals ALNY NASDAQ Health Care Gene Editing - Cell Therapies USD 139.02 16 B 8.8% Neutral 44%   0% -27%
ALX Oncology Holdings ALXO NASDAQ Health Care Oncology USD 60.35 2.2 B 101.2% Weak Down 83%   0% -73%
Amarin AMRN NASDAQ Health Care Drug Manufacturers -Specialty Pharma USD 5.01 1.9 B -18.4% Weak Down 70%   0% -56%
Amgen AMGN NASDAQ Health Care Biopharmaceuticals USD 255.13 149 B 12.6% Weak Up 26%   0% -16%
Amicus Therapeutics Inc. FOLD NASDAQ Health Care Drug Manufacturers - Diversified USD 10.33 2.7 B -2.6% Sharp Down 66%   0% -63%
Amphastar Pharmaceuticals Inc AMPH NASDAQ Health Care Drug Manufacturers - Generic USD 17.35 824 M 8.5% Neutral 31%   0% -24%
Amyris AMRS NASDAQ Industrial Goods Chemicals - Major USD 15.69 3.8 B 597.3% Weak Down 117%   1% -32%
AnaptysBio ANAB NASDAQ Health Care Biopharmaceuticals USD 22.07 604 M 41.3% Sharp Down 76%   0% -46%
ANI Pharmaceuticals ANIP NASDAQ Health Care Drug Manufacturers - Generic USD 34.76 430 M -18.7% Neutral 51%   0% -48%
Annexon ANNX NASDAQ Health Care Clinical trial work USD 23.93 913 M 20.6% Sharp Down 65%   0% -43%
Apellis Pharmaceuticals APLS NASDAQ Health Care Clinical trial work USD 44.76 3.4 B 41.9% Neutral 61%   0% -29%
Applied Molecular Transport AMTI NASDAQ Health Care Immunotherapy USD 40.35 1.4 B 124.4% Weak Down 89%   0% -76%
Aptinyx APTX NASDAQ Health Care Clinical trial work USD 2.77 175 M 20.4% Sharp Down 76%   0% -44%
Aquestive Therapeutics AQST NASDAQ Health Care Drug Manufacturers -Specialty Pharma USD 4.34 146 M 17.6% Neutral 92%   1% -54%
Arbutus Biopharma ABUS NASDAQ Health Care Biopharmaceuticals USD 3.20 259 M 166.7% Sharp Down 123%   1% -62%
Arcutis Biotherapeutics ARQT NASDAQ Health Care Biopharmaceuticals USD 28.68 1.3 B 7.8% Sharp Down 77%   0% -51%
Ardelyx ARDX NASDAQ Health Care Biopharmaceuticals USD 8.66 782 M 25.9% Weak Up 57%   1% -38%
Arena Pharmaceuticals ARNA NASDAQ Health Care Cannabinoid Therapeutics USD 67.99 3.9 B 42.9% Sharp Down 50%   0% -27%
argenx SE ARGX NASDAQ Health Care Biopharmaceuticals USD 277.47 12 B 94.6% Sharp Down 50%   0% -31%
Arrowhead Pharmaceuticals ARWR NASDAQ Health Care Gene Editing - Cell Therapies USD 67.98 7.0 B 95.2% Sharp Down 67%   1% -32%
Ascendis Pharma ASND NASDAQ Health Care Biopharmaceuticals USD 124.18 6.5 B -3.4% Sharp Down 37%   0% -32%
Asertio Therapeutics ASRT NASDAQ Health Care Biopharmaceuticals USD 0.53 57 M -40.4% Sharp Down 97%   0% -69%
Atara Biotherapeutics ATRA NASDAQ Health Care Immunotherapy USD 13.94 1.1 B 69.6% Sharp Down 73%   1% -48%
Athenex ATNX NASDAQ Health Care Drug Manufacturers - Diversified USD 4.12 385 M -48.7% Sharp Down 103%   0% -73%
Aurinia Pharmaceuticals AUPH NASDAQ Health Care Clinical trial work USD 12.60 1.4 B -18.8% Sharp Down 59%   0% -34%
Avadel Pharmaceuticals (ADR) AVDL NASDAQ Health Care Biopharmaceuticals USD 8.55 498 M -8.8% Neutral 71%   0% -57%
AVROBIO AVRO NASDAQ Health Care Gene Editing - Cell Therapies USD 11.50 419 M -8.1% Weak Down 79%   1% -54%
Beam Therapeutics BEAM NASDAQ Health Care Gene Editing - Cell Therapies USD 73.78 4.3 B 356.3% Sharp Down 92%   1% -43%
BeiGene BGNE NASDAQ Health Care Gene Editing - Cell Therapies USD 307.81 28 B 96.2% Neutral 51%   0% -30%
Bellicum Pharmaceuticals BLCM NASDAQ Health Care Biopharmaceuticals USD 3.40 17 M -47.9% Sharp Down 107%   1% -70%
Bio-Techne TECH NASDAQ Health Care Diagnostics USD 415.18 16 B 96.3% Weak Up 38%   0% -16%
BioCryst Pharmaceuticals BCRX NASDAQ Health Care Biopharmaceuticals USD 11.34 2.0 B 337.8% Weak Down 92%   1% -30%
Biogen BIIB NASDAQ Health Care Biopharmaceuticals USD 270.44 42 B -20.1% Neutral 59%   0% -34%
BioMarin Pharmaceutical BMRN NASDAQ Health Care Biopharmaceuticals USD 78.77 14 B -7.6% Neutral 55%   0% -45%
Black Diamond Therapeutics BDTX NASDAQ Health Care Oncology USD 25.22 908 M -9.2% Neutral 67%   0% -50%
bluebird bio, Inc. BLUE NASDAQ Health Care Biopharmaceuticals USD 29.72 2.0 B -43.5% Sharp Down 74%   0% -64%
Blueprint Medicines Corp BPMC NASDAQ Health Care Biopharmaceuticals USD 95.95 5.3 B 41.4% Weak Down 50%   0% -27%
Cabaletta Bio CABA NASDAQ Health Care Gene Editing - Cell Therapies USD 10.75 259 M 60.7% Weak Down 76%   0% -34%
Calyxt CLXT NASDAQ Agriculture Farm Crops & Crop Protection USD 5.61 186 M 38.2% Sharp Down 103%   1% -53%
Cara Therapeutics CARA NASDAQ Health Care Cannabinoid Therapeutics USD 28.31 1.4 B 100.8% Strong Up 48%   0% -31%
Cellectis (ADR) CLLS NASDAQ Health Care Gene Editing - Cell Therapies USD 19.30 820 M 67.8% Sharp Down 87%   1% -45%
Cerus Corporation CERS NASDAQ Health Care Medical Devices USD 6.35 1.1 B 23.5% Neutral 57%   0% -34%
ChemoCentryx, Inc. CCXI NASDAQ Health Care Biopharmaceuticals USD 47.15 3.3 B 0.7% Sharp Down 53%   0% -32%
Chimerix CMRX NASDAQ Health Care Biopharmaceuticals USD 8.31 520 M 446.7% Weak Down 100%   0% -27%
China Biologic Products CBPO NASDAQ Health Care Biopharmaceuticals USD 118.06 4.6 B 8.4% Neutral 13%   0% -8%
Clovis Oncology, Inc. CLVS NASDAQ Health Care Biopharmaceuticals USD 6.10 539 M -17.1% Neutral 96%   1% -57%
Cogent Biosciences COGT NASDAQ Health Care Immunotherapy USD 9.08 103 M 521.9% Neutral 182%   0% -44%
Coherus BioSciences CHRS NASDAQ Health Care Biopharmaceuticals USD 14.24 1.0 B -5.1% Sharp Down 48%   0% -36%
Collegium Pharmaceutical COLL NASDAQ Health Care Biopharmaceuticals USD 23.46 811 M 23.6% Neutral 50%   0% -33%
Corbus Pharmaceuticals Holdings CRBP NASDAQ Health Care Cannabinoid Therapeutics USD 1.76 148 M -68.7% Sharp Down 173%   1% -90%
Corvus Pharmaceuticals CRVS NASDAQ Health Care Biopharmaceuticals USD 2.78 78 M 11.2% Sharp Down 101%   0% -49%
Crinetics Pharmaceuticals CRNX NASDAQ Health Care Clinical trial work USD 17.32 570 M 11.9% Neutral 71%   1% -48%
CRISPR Therapeutics CRSP NASDAQ Health Care Gene Editing - Cell Therapies USD 123.85 8.8 B 150.2% Sharp Down 64%   1% -47%
Curis Inc. CRIS NASDAQ Health Care Biopharmaceuticals USD 12.21 718 M 1,506.6% Weak Up 179%   1% -30%
Cymabay Therapeutics CBAY NASDAQ Health Care Clinical trial work USD 4.32 298 M 161.8% Sharp Down 111%   1% -54%
Cytokinetics Inc. CYTK NASDAQ Health Care Biopharmaceuticals USD 24.87 1.8 B 77.8% Strong Up 88%   0% -47%
CytomX Therapeutics CTMX NASDAQ Health Care Biopharmaceuticals USD 7.65 353 M -16.5% Weak Down 79%   1% -56%
DBV Technologies (ADR) DBVT NASDAQ Health Care Clinical trial work USD 6.25 588 M 46.7% Neutral 106%   0% -78%
Deciphera Pharmaceuticals DCPH NASDAQ Health Care Clinical trial work USD 47.23 2.7 B 8.8% Neutral 57%   0% -39%
Denali Therapeutics DNLI NASDAQ Health Care Clinical trial work USD 56.04 6.7 B 189.6% Sharp Down 74%   0% -46%
Dicerna Pharmaceuticals DRNA NASDAQ Health Care Biopharmaceuticals USD 28.53 2.1 B 36.4% Neutral 60%   1% -36%
Eagle Pharmaceuticals Inc EGRX NASDAQ Health Care Drug Manufacturers -Specialty Pharma USD 44.31 577 M -13.9% Neutral 38%   0% -33%
Editas Medicine EDIT NASDAQ Health Care Gene Editing - Cell Therapies USD 40.98 2.6 B 76.3% Sharp Down 86%   1% -56%
Eidos Therapeutics EIDX NASDAQ Health Care Clinical trial work USD 122.21 4.7 B 170.4% Strong Up 59%   0% -11%
Eiger BioPharmaceuticals EIGR NASDAQ Health Care Biopharmaceuticals USD 8.40 273 M 7.4% Sharp Down 74%   1% -40%
Eloxx Pharmaceuticals ELOX NASDAQ Health Care Clinical trial work USD 2.76 111 M 40.5% Sharp Down 81%   0% -42%
Enanta Pharmaceuticals Inc ENTA NASDAQ Health Care Biopharmaceuticals USD 51.76 1.0 B -4.0% Neutral 39%   0% -29%
Endo International ENDP NASDAQ Health Care Drug Manufacturers - Generic USD 6.05 1.4 B 57.6% Sharp Down 70%   0% -43%
Epizyme, Inc. EPZM NASDAQ Health Care Biopharmaceuticals USD 8.23 835 M -51.8% Sharp Down 64%   0% -64%
Esperion Therapeutics ESPR NASDAQ Health Care Drug Manufacturers -Specialty Pharma USD 27.04 752 M -24.6% Weak Down 65%   0% -54%
Evolus EOLS NASDAQ Health Care Drug Manufacturers -Specialty Pharma USD 11.27 380 M 161.5% Neutral 113%   0% -32%
Exelixis EXEL NASDAQ Health Care Oncology USD 23.95 7.4 B 29.2% Neutral 47%   0% -33%
EyePoint Pharmaceuticals EYPT NASDAQ Health Care Biopharmaceuticals USD 9.59 138 M 6.6% Weak Down 87%   0% -64%
Fate Therapeutics FATE NASDAQ Health Care Oncology USD 84.40 7.3 B 192.6% Sharp Down 77%   1% -39%
FibroGen FGEN NASDAQ Health Care Biopharmaceuticals USD 19.30 1.8 B -48.0% Sharp Down 81%   0% -67%
Five Prime Therapeutics FPRX NASDAQ Health Care Drug Manufacturers -Specialty Pharma USD 38.00 1.4 B 1,339.4% Strong Up 161%   0% -38%
Flexion Therapeutics FLXN NASDAQ Health Care Biopharmaceuticals USD 9.67 477 M 27.9% Sharp Down 69%   0% -41%
Forma Therapeutics Holdings FMTX NASDAQ Health Care Clinical trial work USD 28.33 1.2 B -27.4% Sharp Down 66%   0% -52%
Frequency Therapeutics FREQ NASDAQ Health Care Biopharmaceuticals USD 9.80 331 M -35.1% Sharp Down 171%   1% -85%
G1 Therapeutics GTHX NASDAQ Health Care Biopharmaceuticals USD 25.11 955 M 88.7% Weak Up 75%   1% -55%
Galapagos GLPG NASDAQ Health Care Biopharmaceuticals USD 79.39 5.1 B -61.5% Sharp Down 56%   0% -67%
Gamida Cell GMDA NASDAQ Health Care Oncology USD 7.82 263 M 99.5% Sharp Down 92%   0% -38%
Generation Bio GBIO NASDAQ Health Care Gene Editing - Cell Therapies USD 27.52 1.3 B 11.5% Sharp Down 82%   0% -52%
Genmab A/S GMAB NASDAQ Health Care Biopharmaceuticals USD 34.98 23 B 58.0% Neutral 35%   0% -30%
Geron GERN NASDAQ Health Care Drug Manufacturers - Diversified USD 1.51 469 M 29.1% Sharp Down 66%   1% -35%
Gilead Sciences GILD NASDAQ Health Care Biopharmaceuticals USD 65.77 82 B -10.5% Neutral 28%   0% -30%
Global Blood Therapeutics GBT NASDAQ Health Care Biopharmaceuticals USD 41.33 2.5 B -38.9% Sharp Down 69%   0% -54%
GlycoMimetics GLYC NASDAQ Health Care Clinical trial work USD 2.55 122 M 1.2% Weak Down 65%   1% -49%
Grifols SA GRFS NASDAQ Health Care Drug Manufacturers - Diversified USD 18.27 13 B -13.0% Weak Up 34%   0% -28%
GW Pharmaceuticals (ADR) GWPH NASDAQ Health Care Cannabinoid Therapeutics USD 218.81 6.8 B 124.9% Strong Up 57%   0% -36%
Halozyme Therapeutics HALO NASDAQ Health Care Biopharmaceuticals USD 46.20 6.3 B 148.5% Neutral 43%   0% -23%
Homology Medicines FIXX NASDAQ Health Care Gene Editing - Cell Therapies USD 7.03 318 M -50.6% Sharp Down 72%   1% -58%
Horizon Pharma HZNP NASDAQ Health Care Drug Manufacturers -Specialty Pharma USD 93.51 19 B 184.8% Neutral 52%   0% -21%
Hutchison China MediTech HCM NASDAQ Health Care Drug Manufacturers -Specialty Pharma USD 29.38 3.9 B 58.2% Neutral 44%   0% -27%
I-Mab IMAB NASDAQ Health Care Immunotherapy USD 57.14 - 303.8% Neutral 87%   0% -31%
IDEAYA Biosciences IDYA NASDAQ Health Care Oncology USD 18.70 544 M 336.9% Weak Down 98%   0% -40%
Illumina ILMN NASDAQ Health Care Gene Editing - Cell Therapies USD 401.96 59 B 32.4% Weak Down 41%   0% -27%
Immunogen IMGN NASDAQ Health Care Biopharmaceuticals USD 7.70 1.4 B 120.6% Weak Down 75%   1% -32%
Incyte Corporation INCY NASDAQ Health Care Drug Manufacturers -Specialty Pharma USD 83.20 18 B -13.0% Neutral 38%   0% -31%
Innoviva INVA NASDAQ Health Care Biopharmaceuticals USD 11.89 1.2 B -5.3% Neutral 39%   0% -39%
Inovio Pharmaceuticals INO NASDAQ Health Care Biopharmaceuticals USD 9.01 1.5 B 14.2% Sharp Down 133%   1% -74%
Inozyme Pharma INZY NASDAQ Health Care Biopharmaceuticals USD 20.05 469 M 14.3% Neutral 66%   0% -42%
Insmed INSM NASDAQ Health Care Biopharmaceuticals USD 33.62 3.4 B 93.4% Sharp Down 58%   0% -30%
Intellia Therapeutics NTLA NASDAQ Health Care Gene Editing - Cell Therapies USD 74.77 4.4 B 459.7% Weak Up 87%   1% -44%
Intercept Pharmaceuticals ICPT NASDAQ Health Care Biopharmaceuticals USD 20.55 678 M -72.5% Neutral 88%   0% -79%
Intra-Cellular Therapies, Inc. ITCI NASDAQ Health Care Drug Manufacturers -Specialty Pharma USD 32.35 2.6 B 93.8% Weak Down 77%   0% -34%
Ionis Pharmaceuticals IONS NASDAQ Health Care Biopharmaceuticals USD 41.03 5.7 B -23.0% Sharp Down 44%   0% -36%
Iovance Biotherapeutics IOVA NASDAQ Health Care Immunotherapy USD 30.43 4.5 B -13.6% Sharp Down 59%   0% -45%
Ironwood Pharmaceuticals IRWD NASDAQ Health Care Drug Manufacturers -Specialty Pharma USD 10.84 1.7 B 7.1% Neutral 44%   0% -26%
iTeos Therapeutics ITOS NASDAQ Health Care Oncology USD 23.05 808 M 21.0% Sharp Down 66%   0% -57%
Jazz Pharmaceuticals JAZZ NASDAQ Health Care Drug Manufacturers -Specialty Pharma USD 168.39 9.3 B 56.9% Neutral 36%   0% -12%
Jounce Therapeutics JNCE NASDAQ Health Care Immunotherapy USD 9.71 387 M 104.9% Sharp Down 97%   1% -34%
Kadmon Holdings KDMN NASDAQ Health Care Drug Manufacturers - Generic USD 3.94 - -7.5% Sharp Down 65%   1% -39%
Kala Pharmaceuticals KALA NASDAQ Health Care Biopharmaceuticals USD 7.61 427 M -18.3% Neutral 69%   0% -55%
Karyopharm Therapeutics Inc. KPTI NASDAQ Health Care Drug Manufacturers -Specialty Pharma USD 9.69 713 M -56.2% Sharp Down 60%   0% -62%
Keros Therapeutics KROS NASDAQ Health Care Clinical trial work USD 63.46 1.3 B 120.3% Neutral 72%   0% -65%
Kiniksa Pharmaceuticals KNSA NASDAQ Health Care Clinical trial work USD 16.44 1.1 B -7.0% Sharp Down 69%   0% -43%
Kura Oncology KURA NASDAQ Health Care Biopharmaceuticals USD 29.47 1.7 B 184.7% Neutral 72%   0% -41%
Lexicon Pharmaceuticals LXRX NASDAQ Health Care Diabetes USD 5.21 612 M 160.5% Sharp Down 120%   1% -44%
Ligand Pharmaceuticals LGND NASDAQ Health Care Clinical trial work USD 148.88 2.4 B 68.0% Neutral 57%   0% -35%
Luminex Corp LMNX NASDAQ Health Care Diagnostics USD 36.80 1.7 B 18.1% Neutral 54%   0% -48%
Lumos Pharma LUMO NASDAQ Health Care Biopharmaceuticals USD 11.93 99 M 43.0% Sharp Down 70%   0% -70%
MacroGenics MGNX NASDAQ Health Care Biopharmaceuticals USD 32.60 1.8 B 526.9% Strong Up 141%   1% -40%
Magenta Therapeutics MGTA NASDAQ Health Care Gene Editing - Cell Therapies USD 10.83 523 M 37.6% Neutral 70%   0% -43%
MannKind Corporation MNKD NASDAQ Health Care Diabetes USD 4.30 1.0 B 252.5% Weak Up 90%   1% -48%
Marinus Pharmaceuticals MRNS NASDAQ Health Care Clinical trial work USD 14.36 439 M 100.6% Weak Down 86%   0% -50%
MediciNova Inc. MNOV NASDAQ Health Care Drug Manufacturers - Diversified USD 4.65 209 M -14.2% Sharp Down 109%   0% -59%
Medpace Holdings MEDP NASDAQ Health Care Medical Laboratories & Research USD 185.00 6.6 B 124.8% Weak Up 40%   0% -18%
Mersana Therapeutics MRSN NASDAQ Health Care Biopharmaceuticals USD 17.27 1.2 B 103.7% Sharp Down 95%   1% -45%
Minerva Neurosciences NERV NASDAQ Health Care Biopharmaceuticals USD 2.51 107 M -61.3% Sharp Down 147%   0% -85%
Mirati Therapeutics MRTX NASDAQ Health Care Oncology USD 164.05 8.2 B 88.4% Sharp Down 49%   0% -34%
Myriad Genetics MYGN NASDAQ Health Care Diagnostics USD 28.76 2.2 B 98.2% Neutral 62%   0% -35%
Nabriva Therapeutics NBRV NASDAQ Health Care Clinical trial work USD 1.57 237 M -69.0% Sharp Down 101%   0% -87%
NanoString Technologies NSTG NASDAQ Health Care Diagnostics USD 74.17 3.3 B 171.9% Neutral 64%   0% -31%
NantHealth NH NASDAQ Health Care Health Care Information Technology USD 2.61 290 M 31.2% Sharp Down 102%   0% -67%
NantKwest, Inc. NK NASDAQ Health Care Biopharmaceuticals USD 32.49 3.5 B 875.7% Neutral 124%   1% -39%
Nektar Therapeutics NKTR NASDAQ Health Care Clinical trial work USD 19.36 3.5 B 5.4% Weak Down 48%   0% -36%
Neoleukin Therapeutics NLTX NASDAQ Health Care Immunotherapy USD 12.20 511 M -3.9% Neutral 79%   0% -43%
Neos Therapeutics NEOS NASDAQ Health Care Drug Manufacturers -Specialty Pharma USD 1.15 57 M 19.9% Weak Up 100%   0% -53%
Neurocrine Biosciences NBIX NASDAQ Health Care Biopharmaceuticals USD 95.00 8.9 B -0.2% Neutral 47%   0% -36%
Neuronetics STIM NASDAQ Health Care Biopharmaceuticals USD 12.18 231 M 466.5% Sharp Down 101%   0% -46%
Nkarta NKTX NASDAQ Health Care Gene Editing - Cell Therapies USD 36.68 1.2 B 38.0% Sharp Down 72%   0% -65%
Novavax NVAX NASDAQ Health Care Clinical trial work USD 202.09 13 B 1,016.5% Neutral 130%   1% -51%
NovoCure NVCR NASDAQ Health Care Biopharmaceuticals USD 198.83 20 B 187.0% Weak Up 69%   0% -35%
Nurix Therapeutics NRIX NASDAQ Health Care Biopharmaceuticals USD 30.99 1.2 B 62.1% Sharp Down 97%   0% -62%
Ocular Therapeutix OCUL NASDAQ Health Care Biopharmaceuticals USD 16.15 1.2 B 203.6% Weak Down 73%   0% -31%
Omeros Corp OMER NASDAQ Health Care Biopharmaceuticals USD 18.41 1.1 B 30.7% Sharp Down 76%   0% -55%
OPKO Health OPK NASDAQ Health Care Diagnostics USD 4.32 2.9 B 157.1% Weak Down 87%   1% -50%
OptiNose OPTN NASDAQ Health Care Drug Manufacturers -Specialty Pharma USD 3.59 187 M -5.0% Sharp Down 76%   0% -57%
ORIC Pharmaceuticals ORIC NASDAQ Health Care Oncology USD 21.91 757 M -15.0% Sharp Down 78%   0% -51%
Pacific Biosciences of California PACB NASDAQ Health Care Medical Technology USD 32.85 5.9 B 1,025.0% Neutral 85%   1% -46%
Pacira Pharmaceuticals PCRX NASDAQ Health Care Drug Manufacturers -Specialty Pharma USD 66.34 2.9 B 96.8% Weak Down 46%   0% -20%
Paratek Pharmaceuticals PRTK NASDAQ Health Care Biopharmaceuticals USD 8.12 371 M 79.6% Neutral 58%   0% -32%
Passage Bio PASG NASDAQ Health Care Gene Editing - Cell Therapies USD 17.20 783 M -14.5% Sharp Down 80%   0% -66%
PDL BioPharma PDLI NASDAQ Health Care Biopharmaceuticals USD 2.47 288 M 21.1% Weak Up 42%   0% -19%
PetIQ PETQ NASDAQ Health Care Veterinary Services USD 36.59 1.1 B 65.3% Neutral 52%   0% -33%
Pliant Therapeutics PLRX NASDAQ Health Care Biopharmaceuticals USD 30.64 1.1 B 43.8% Weak Down 78%   0% -47%
PRA Health Sciences PRAH NASDAQ Health Care Clinical trial work USD 161.80 10 B 89.5% Strong Up 37%   0% -15%
Precigen PGEN NASDAQ Health Care Biopharmaceuticals USD 7.82 1.5 B 187.5% Sharp Down 121%   1% -38%
ProQR Therapeutics PRQR NASDAQ Health Care Gene Editing - Cell Therapies USD 6.18 334 M 22.4% Neutral 86%   0% -35%
Prothena Corp PRTA NASDAQ Health Care Biopharmaceuticals USD 25.65 1.0 B 123.8% Neutral 80%   0% -22%
Provention Bio PRVB NASDAQ Health Care Immunotherapy USD 8.08 456 M -20.3% Sharp Down 77%   1% -60%
PTC Therapeutics PTCT NASDAQ Health Care Biopharmaceuticals USD 48.19 3.3 B 1.5% Sharp Down 45%   0% -32%
Puma Biotechnology PBYI NASDAQ Health Care Biopharmaceuticals USD 10.21 406 M 18.7% Weak Down 67%   1% -41%
Quanterix QTRX NASDAQ Health Care Medical Laboratories & Research USD 63.61 2.0 B 173.5% Neutral 75%   0% -43%
Radius Health RDUS NASDAQ Health Care Biopharmaceuticals USD 19.74 919 M 42.6% Weak Down 62%   0% -27%
Regeneron Pharmaceuticals REGN NASDAQ Health Care Biopharmaceuticals USD 494.64 53 B -8.4% Neutral 35%   0% -32%
REGENXBIO RGNX NASDAQ Health Care Gene Editing - Cell Therapies USD 35.87 1.3 B 7.8% Sharp Down 57%   1% -39%
Relay Therapeutics RLAY NASDAQ Health Care Oncology USD 33.73 3.0 B -3.8% Sharp Down 67%   0% -48%
Relmada Therapeutics RLMD NASDAQ Health Care Clinical trial work USD 36.40 591 M 3.4% Neutral 52%   0% -40%
Repare Therapeutics RPTX NASDAQ Health Care Oncology USD 34.05 - 10.6% Weak Up 60%   0% -42%
Repligen RGEN NASDAQ Health Care Products & Processes USD 213.57 11 B 103.1% Neutral 45%   0% -20%
Replimune Group REPL NASDAQ Health Care Immunotherapy USD 31.09 1.4 B 170.8% Sharp Down 86%   0% -44%
Revance Therapeutics, Inc. RVNC NASDAQ Health Care Drug Manufacturers -Specialty Pharma USD 28.16 1.9 B 83.3% Neutral 54%   0% -32%
Revolution Medicines RVMD NASDAQ Health Care Oncology USD 39.09 2.6 B 75.8% Weak Down 73%   0% -31%
Rhythm Pharmaceuticals RYTM NASDAQ Health Care Biopharmaceuticals USD 20.74 917 M 18.5% Sharp Down 64%   0% -49%
Rigel Pharmaceuticals RIGL NASDAQ Health Care Biopharmaceuticals USD 3.78 639 M 131.9% Neutral 95%   1% -46%
Rocket Pharmaceuticals RCKT NASDAQ Health Care Gene Editing - Cell Therapies USD 43.80 2.4 B 185.2% Sharp Down 89%   1% -40%
Rubius Therapeutics RUBY NASDAQ Health Care Gene Editing - Cell Therapies USD 24.05 1.9 B 406.3% Strong Up 127%   1% -30%
SAGE Therapeutics SAGE NASDAQ Health Care Biopharmaceuticals USD 75.50 3.9 B 162.2% Neutral 55%   0% -27%
Sangamo Therapeutics SGMO NASDAQ Health Care Gene Editing - Cell Therapies USD 11.77 1.7 B 62.6% Neutral 80%   1% -40%
Sanofi (ADR) SNY NASDAQ Health Care Drug Manufacturers - Diversified USD 50.69 127 B 13.7% Weak Up 23%   0% -15%
Savara SVRA NASDAQ Health Care Clinical trial work USD 1.68 91 M -26.0% Neutral 85%   0% -67%
Seagen SGEN NASDAQ Health Care Oncology USD 149.64 27 B 12.2% Neutral 45%   0% -35%
Seres Therapeutics MCRB NASDAQ Health Care Biopharmaceuticals USD 21.39 2.0 B 464.4% Neutral 179%   1% -53%
SIGA Technologies Inc. SIGA NASDAQ Health Care Drug Manufacturers - Diversified USD 7.15 559 M 28.8% Neutral 39%   0% -19%
Sio Gene Therapies SIOX NASDAQ